Skip to main content
. 2014 Apr 23;2014:303929. doi: 10.1155/2014/303929

Table 4.

Factors with impact on patients' survival (Cox regression analysis).

Disease specific survival Overall survival
P value HR 95% CI Adjusteda   P value Adjusted HR 95% CI P value HR 95% CI Adjusteda   P value Adjusted HR 95% CI
Gender
 Female Referent Referent Referent Referent
 Male 0.277 0.326 0.043–2.458 0.356 0.385 0.051–2.929 0.099 0.300 0.072–1.253 0.126 0.327 0.078–1.370
Age 0.035 0.972 0.920–1.026 NA 0.892 1.003 0.963–1.044 NA
Tobacco
 Nonsmoker Referent Referent Referent Referent
 Smoker 0.218 0.623 0.293–1.323 0.435 0.740 0.347–1.576 0.019 0.505 0.285–0.894 0.021 0.496 0.274–0.898
Alcohol
 No Referent Referent Referent Referent
 Yes 0.971 1.010 0.586–1.741 0.837 1.059 0.615–1.822 0.505 1.506 0.452–5.017 0.864 0.966 0.647–1.440
Tumor size
 T1 + T2 Referent Referent Referent Referent
 T3 + T4 0.187 1.930 0.727–5.127 0.151 2.061 0.768–5.529 0.027 2.192 1.092–4.396 0.021 2.296 1.135–4.646
Nodal status
 N0 Referent Referent Referent Referent
 N1–N3 0.091 3.565 0.959–1.033 0.020 6.035 1.334–27.305 0.188 1.700 0.771–3.747 0.064 2.228 0.995–5.194
Tumor grade
 G1 Referent Referent Referent Referent
 G2 + G3 0.980 1.006 0.627–1.616 0.932 1.018 0.683–1.516 0.408 1.102 0.875–1.388 0.498 1.080 0.864–1.350
Tumor location
 Oropharyngeal Referent Referent Referent Referent
 Oral 0.631 1.363 0.386–4.814 0.993 1.006 0.277–3.653 0.812 0.881 0.309–2.51 0.508 0.697 0.239–2.029
Recurrence
 No Referent Referent Referent Referent
 Yes 0.0001 12.208 4.591–32.46 0.001 10.503 3.843–28.705 0.0001 6.936 3.372–14.268 0.0001 6.711 3.192–14.111
Tregs 0.054 0.917 0.840–1.001 0.061 0.920 0.843–1.004 0.459 0.984 0.943–1.027 0.525 0.986 0.956–1.029
Tregs
 Low Referent Referent Referent Referent
 High 0.098 0.428 0.157–1.171 0.085 0.413 0.151–1.129 0.097 0.563 0.286–1.109 0.103 0.568 0.269–1.123
CD4+ 0.929 1.003 0.946–1.063 0.772 0.991 0.936–1.051 0.815 0.995 0.956–1.036 0.615 0.990 0.951–1.030
CD8+ 0.260 1.032 0.956–1.105 1.091 1.027 0.972–1.085 0.199 1.026 0.987–1.066 0.236 10.023 0.985–1.063
CD4+CD8+sum 0.202 1.038 0.980–1.098 0.472 1.021 0.964–1.082 0.272 1.023 0.982–1.065 0.443 1.012 0.974–1.061
CD4+/CD8+ 0.274 0.701 0.371–1.325 0.246 0.693 0.373–1.288 0.154 0.735 0.481–1.112 0.129 0.725 0.479–1.098
CD8+/Tregs 0.001 1.211 1.098–1.336 0.001 1.187 1.074–1.311 0.004 1.150 1.045–1.266 0.012 1.136 1.029–1.253
CD19 0.851 0.991 0.905–1.085 0.953 1.003 0.921–1.091 0.617 0.986 0.924–1.052 0.853 0.994 0.932–1.060
CD3–56+16+ 0.020 0.885 0.798–0.981 0.062 0.905 0.815–1.005 0.295 0.986 0.911–1.029 0.409 0.974 0.915–1.037
HPV DNA            
 Negative Referent     Referent
 Positive 0.057 0.335 0.109–1.033 NA 0.125 0.582 0.292–1.162 NA

aadjusted for HPV and age, HR: hazard ratio 95% CI: confidence interval; P: probability.